|
If you've got a fire in your belly, Prometheus Laboratories can help to put it out. The pharmaceutical company markets several drugs that treat gastrointestinal disorders, such as irritable bowel syndrome and ulcerative colitis. Its Entocort, which it co-promotes with AstraZeneca, is a steroid that reduces the bowel inflammation associated with Crohn's disease. Prometheus Laboratories markets its products mainly to US gastroenterologists (about 12,000 of them). It also pairs its drug offerings with a diagnostic testing service that helps doctors differentiate between various gastrointestinal diseases and prescribe the right Prometheus remedy; it runs all of its tests at its San Diego lab facility.
|
| | | Contact Information | |
Address: |
9410 Carroll Park Dr.
San Diego, CA 92121
| | Phone: | 858-824-0895 | | Fax: | 858-824-0896 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 278.10 M | | Revenue Growth (1 yr): | 25.90% | | Employees (2008): | 427 | | Employee Growth (1 yr): | 3.60% |
|
|
Key People
| | • |
Chairman:
Timothy R. G. (Tim) Sear
| | • |
President, CEO, and Director:
Joseph M. (Joe) Limber
| | • |
SVP Finance and CFO:
Mark E. Spring
|
|
|
